Company: IMNN
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0001641172-25-014324
Chunk: 66

Company: Imunon, Inc.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 66
---
 of shares of our Common Stock or restricted stock or options or warrants to purchase shares of our Common Stock. The Reverse Stock Split would result in the increased number of available authorized shares of Common Stock, some of which could be used as compensation for non-employee directors or executive directors in connection with equity compensation plans. All such plans have been approved (or will be approved) by the stockholders of the Company at general meetings.

Vote Required for Approval

For the Reverse Stock Split proposal to be approved, the number of votes cast “FOR” the proposal must exceed the number of votes cast “AGAINST” the proposal; provided that our common stock meets the Listing Condition, in which case, abstentions with respect to the proposal will not be considered “votes cast” and will have no effect on the proposal. If the Listing Condition is not met, the proposal must receive the affirmative vote of the holders of a majority of our issued and outstanding shares of common stock as of the Record Date, and any abstentions with respect to the proposal would have the same effect as a vote “AGAINST” the proposal. Brokerage firms have authority to vote customers’ unvoted shares held by the firms in street name on this proposal. If the Listing Condition is met, any broker non-votes (if any) will have no effect on the proposal. If the Listing Condition is not met, any broker non-votes (if any) will be treated as a vote “AGAINST” the proposal.

<div align='center'>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE AMENDMENT TO THE COMPANY’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT

AT A RATIO BETWEEN, AND INCLUDING, 1:5 and1:18, WITH THE EXACT RATIO TO BE set within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders (the “Reverse Stock Split”)</div>

| 50 |

<div align='center'>PROPOSAL NO. 7:

AMENDMENT OF THE IMUNON, INC. 2018 STOCK INCENTIVE PLAN</div>

BACKGROUND

At the 2025 Annual Meeting, stockholders will be asked to approve the following amendment to the 2018 Plan, which amendment was approved by our Board of Directors on March 14, 2025.

Increase in Aggregate Share Limit.The 2018 Plan currently limits the aggregate number of shares of common stock